Case studies

Real FDA problems, solved in days.

Complizen does the analysis in seconds. Then an FDA expert checks every line of it. Here are two clients, what we found, and what we did next. Each page also says where the work stands today.

Talk to an expert

Ortolog · DKS Ortho

  1. Complizen finds the path

    It gives you the FDA path, the full list of what that path needs, and what your documents already cover. This takes seconds, not weeks.

  2. An FDA expert checks it

    A person reads every line before you do. We never send you an answer that only a computer has read.

  3. You get clear next steps

    Not a long report to decode. A list of what to do, in order, with the time each step takes.

After a letter from FDA

Deficiency letter answered, Q-Sub prepared

FDA sent Ortolog a long list of problems. They had 180 days to reply. We used a small part of that time.

Answers sent long before FDA's 180-day deadline
Months earlyAnswers sent long before FDA's 180-day deadline
For Complizen to turn FDA's letter into a plan
SecondsFor Complizen to turn FDA's letter into a plan
To prepare their Q-Sub request
3 daysTo prepare their Q-Sub request
OrtologAfter a letter from FDARead the story
Before the first submission

Regulatory strategy and testing plan, listed in 4 days

DKS Ortho makes knee implants in India. They wanted to sell in the US. First they needed to know what the testing would cost.

To a written plan and the full test list
4 daysTo a written plan and the full test list
For Complizen to classify the devices and find the FDA path
SecondsFor Complizen to classify the devices and find the FDA path
Testing runs now, at labs we found for them
In progressTesting runs now, at labs we found for them
DKS OrthoBefore the first submissionRead the story

Both started the same way. Someone told us about their device.

Tell us what you make and how far you have got. You get your FDA path, the full list of what a submission needs, and what your documents already cover.

Talk to an expert

One reply from a reviewer. No card, no sequence.